ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,835,230 | -38.9% | 179,949 | -18.9% | 0.01% | -40.0% |
| Q2 2023 | $7,915,486 | +35.2% | 221,971 | -3.7% | 0.01% | +25.0% |
| Q1 2023 | $5,854,904 | -43.8% | 230,508 | -10.3% | 0.01% | -46.7% |
| Q4 2022 | $10,420,392 | +25.0% | 256,913 | +1.8% | 0.02% | +25.0% |
| Q3 2022 | $8,337,127 | +3.8% | 252,258 | +10.6% | 0.01% | -40.0% |
| Q2 2022 | $8,032,000 | +16.3% | 228,111 | +51.9% | 0.02% | +42.9% |
| Q1 2022 | $6,905,000 | -2.1% | 150,132 | +41.2% | 0.01% | 0.0% |
| Q4 2021 | $7,051,000 | -57.9% | 106,349 | -60.4% | 0.01% | -58.8% |
| Q3 2021 | $16,750,000 | -24.6% | 268,313 | +0.0% | 0.03% | -20.9% |
| Q2 2021 | $22,213,000 | +19.4% | 268,215 | -4.4% | 0.04% | +13.2% |
| Q1 2021 | $18,604,000 | -18.0% | 280,580 | -5.1% | 0.04% | -17.4% |
| Q4 2020 | $22,693,000 | +46.2% | 295,747 | -18.0% | 0.05% | +35.3% |
| Q3 2020 | $15,522,000 | -3.3% | 360,459 | -3.0% | 0.03% | -8.1% |
| Q2 2020 | $16,049,000 | +18.0% | 371,611 | -21.4% | 0.04% | 0.0% |
| Q1 2020 | $13,606,000 | -50.5% | 472,933 | +9.1% | 0.04% | -35.1% |
| Q4 2019 | $27,504,000 | +1513.1% | 433,617 | +616.8% | 0.06% | +1325.0% |
| Q3 2019 | $1,705,000 | +6.0% | 60,493 | -0.3% | 0.00% | +33.3% |
| Q2 2019 | $1,608,000 | +135.4% | 60,681 | +63.1% | 0.00% | +50.0% |
| Q1 2019 | $683,000 | +52.1% | 37,212 | +2.9% | 0.00% | +100.0% |
| Q4 2018 | $449,000 | -31.1% | 36,149 | +6.3% | 0.00% | 0.0% |
| Q3 2018 | $652,000 | +41.1% | 33,998 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $462,000 | +842.9% | 33,998 | +28.8% | 0.00% | – |
| Q1 2017 | $49,000 | +19.5% | 26,392 | 0.0% | 0.00% | – |
| Q4 2016 | $41,000 | -78.9% | 26,392 | 0.0% | 0.00% | – |
| Q3 2016 | $194,000 | +38.6% | 26,392 | 0.0% | 0.00% | – |
| Q2 2016 | $140,000 | – | 26,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |